Copyright © Inderes 2011 - present. All rights reserved.

Klaria Pharma Holding

0.77 SEK

-0.26 %

Less than 1K followers

KLAR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-0.26 %
-14.41 %
+15.92 %
+37.86 %
+55.96 %
-53.41 %
+13.62 %
-86.11 %
-83.11 %

Klaria Pharma Holding operates in the pharmaceutical industry. The business is focused on developing and commercializing solutions in the therapeutic areas of migraine and cancer-related pain. The technology is based on the company's drug-delivery platform, where the product consists of an alginate-based polymer film. The film is attached to the patient's oral mucosa, which enables the distribution of drugs in the body. The headquarters are located in Uppsala.

Read more
Market cap
189.89M SEK
Turnover
279.9K SEK
Revenue
2.25M
EBIT %
-1,387.11 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20/2
2026

Annual report '25

21/5
2026

Interim report Q1'26

27/8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.